Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Presti

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia OncologicaG Bolis, N Colombo, S Pecorelli, et al.
Journal of the National Cancer Institute|October 4, 1989
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatinC Mangioni, G Bolis, S Pecorelli, et al.
Cancer|January 15, 1998
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocolR Silvestrini, M G Daidone, S Veneroni, et al.
The Journal of Infectious Diseases|March 19, 2005
Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibioticsRachel C Orscheln, Dwight R Johnson, Stephen M Olson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancerG Bolis, G Scarfone, F Zanaboni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyF Crippa, G L Buraggi, E Di Re, et al.
AIDS (London, England)|June 1, 2018
Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune statusRachel M Presti, Scott A Handley, Lindsay Droit, et al.
Journal of Virology|September 4, 2009
Quaranfil, Johnston Atoll, and Lake Chad viruses are novel members of the family OrthomyxoviridaeRachel M Presti, Guoyan Zhao, Wandy L Beatty, et al.
Chest|April 22, 2017
Mechanisms Underlying HIV-Associated Noninfectious Lung DiseaseRachel M Presti, Sonia C Flores, Brent E Palmer, et al.
Science (New York, N.Y.)|February 5, 2021
CARD8 is an inflammasome sensor for HIV-1 protease activityQiankun Wang, Hongbo Gao, Kolin M Clark, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1995
Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia OncologicaG Bolis, N Colombo, S Pecorelli, et al.
Journal of the National Cancer Institute|October 4, 1989
Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatinC Mangioni, G Bolis, S Pecorelli, et al.
Cancer|January 15, 1998
The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocolR Silvestrini, M G Daidone, S Veneroni, et al.
The Journal of Infectious Diseases|March 19, 2005
Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibioticsRachel C Orscheln, Dwight R Johnson, Stephen M Olson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
A phase I-II trial of fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancerG Bolis, G Scarfone, F Zanaboni, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibodyF Crippa, G L Buraggi, E Di Re, et al.
AIDS (London, England)|June 1, 2018
Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune statusRachel M Presti, Scott A Handley, Lindsay Droit, et al.
Journal of Virology|September 4, 2009
Quaranfil, Johnston Atoll, and Lake Chad viruses are novel members of the family OrthomyxoviridaeRachel M Presti, Guoyan Zhao, Wandy L Beatty, et al.
Chest|April 22, 2017
Mechanisms Underlying HIV-Associated Noninfectious Lung DiseaseRachel M Presti, Sonia C Flores, Brent E Palmer, et al.
Science (New York, N.Y.)|February 5, 2021
CARD8 is an inflammasome sensor for HIV-1 protease activityQiankun Wang, Hongbo Gao, Kolin M Clark, et al.
Pageof 10